oral WDR5 inhibitor

pM Ki, nanomolar in cells

from FBDD, SBDD, and PK opt.

J. Med. Chem.

Vanderbilt University School of Medicine, Nashville, TN

compound 41 chemical structure, oral WDR5 inhibitor - Vanderbilt University School of Medicine, Nashville, TN

Context.  “Compound 41” (Vanderbilt University School of Medicine) is an oral WD40 Repeat Domain 5 (WDR5) inhibitor being developed for various human cancers. The well-established role of epigenetic abnormalities…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: